<DOC>
	<DOCNO>NCT00178503</DOCNO>
	<brief_summary>This study examine cognitive behavioral difference child autism spectrum disorder ( ASD ) without additional symptom ADHD . The study also examine effectiveness range dos methylphenidate improve cognitive behavioral outcome child ASD ADHD .</brief_summary>
	<brief_title>Methylphenidate Attention Deficit Hyperactivity Disorder Autism Children</brief_title>
	<detailed_description>Attention Deficit Hyperactivity Disorder ( ADHD ) major comorbid psychiatric disorder child Autism Spectrum Disorders ( ASD ) significantly undermines behavioral , social , emotional adjustment . Although Diagnostic Statistical Manual Mental Disorders ( DSM-IV ) specifically allow comorbid diagnosis ADHD ASD , many child ASD manifest symptom ADHD treat stimulant medication . The study ADHD ASD consistently establish cognitive behavioral manifestation , optimal parameter treatment . The propose project address issue study cognitive behavioral functioning child ASD , without ADHD , study medication treatment ADHD symptoms autism . Participants age 7 12 autism spectrum disorder participate initial phase study examine nature effect ADHD symptom behavioral cognitive functioning . Participants underwent initial psychological testing session include standardized measure intellectual , adaptive behavior , language , behavioral , emotional functioning , along standardized diagnostic measure confirm diagnose ASD and/or ADHD ( Visit 1 ) . Children intelligence quotient ( IQs ) 50 great 130 major sensory , motor , neurological , genetic , psychiatric disorder may interfere test exclude . The participant meet eligibility criterion complete computerized task attentional function second visit ( Visit 2 ) . A subset child meet criterion ASD/ADHD group ( N=24 ) participate six-week randomized double-blind , placebo-controlled treatment trial use various dos ( low , medium , high dose ) methylphenidate ( MPH ) . Children participate treatment trial qualify base initial phase physical contraindication MPH ( e.g. , history MPH intolerance ) . In week treatment trial , child take one three dos MPH placebo . At end week child evaluate clinic include medical check-up , parent interview child 's behavior function week , computerized cognitive testing . Additionally , child 's parent teacher complete questionnaire child 's behavior week , child 's home school behavior MPH dose could assess .</detailed_description>
	<mesh_term>Autistic Disorder</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Autism/ADHD Group : DSMIV diagnosis autistic disorder , per Autism Diagnostic InterviewRevised ( ADIR ) Autism Diagnostic Observation Schedule ( ADOS ) Child manifest current symptom ADHD Autism/nonADHD Group : Meets diagnostic criterion autism , , meet diagnostic criterion ADHD In group , exclusion criterion include : Sensory motor deficit sufficient interfere test ( e.g. , blindness , severe cerebral palsy ) Serious neurological disorder ( e.g. , epilepsy , stroke ) Down syndrome , fragile X syndrome , Tourette syndrome , fetal alcohol syndrome Bipolar disorder family history bipolar disorder firstdegree relative Other serious psychopathology result psychiatric hospitalization ( e.g. , psychotic episode ) . The investigator screen use Diagnostic Interview Children Adolescents ( DICA ) IV , get complete developmental/medical history Serious physical handicap would interfere performance laboratory task IQ le 50 great 130 Verbal mental age ( VMA ) less 36 month ( exclude participant unable understand simple task instruction ) In autism/ADHD group , exclusion criterion apply MPH trial : History intolerance MPH Weight le 20 kg great 59 kg ( le 44 pound great 130 pound ) Concomitant use dextroamphetamine preparation ( Dexedrine , Dextrostat ) , mixed amphetamine salt ( Adderall XR ) , MPH preparation ( e.g. , Concerta , Metadate ) ; venlafaxine , bupropion , atomoxetine , guanfacine , modafinil . Concomitant use herbal preparation Medical condition stimulant contraindicate ( e.g. , high blood pressure ) Past treatment failure methylphenidate trial</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2013</verification_date>
</DOC>